Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing-Jing Liu

Showing results (361-370 of 365) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 365 results.
Cancer Research|April 15, 2010
A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitroJing-jing Liu, Hui-ni Zeng, Lian-ru Zhang, et al.
Research Square|April 10, 2023
Optopharmacological tools for precise spatiotemporal control of oxytocin signaling in the central nervous system and peripheryIsmail A Ahmed, Jing-Jing Liu, Krystyna A Gieniec, et al.
Cell Metabolism|June 19, 2021
Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1Lin Wang, Xin Zhang, Zhi-Bin Lin, et al.
Journal of Medicinal Chemistry|March 29, 2012
Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivoWei-Wei Li, Xiao-Yan Wang, Ren-Lin Zheng, et al.
Lancet (London, England)|July 24, 2020
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trialFeng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, et al.
Pageof 37

Showing results (361-370 of 365) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 365 results.
Cancer Research|April 15, 2010
A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitroJing-jing Liu, Hui-ni Zeng, Lian-ru Zhang, et al.
Research Square|April 10, 2023
Optopharmacological tools for precise spatiotemporal control of oxytocin signaling in the central nervous system and peripheryIsmail A Ahmed, Jing-Jing Liu, Krystyna A Gieniec, et al.
Cell Metabolism|June 19, 2021
Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1Lin Wang, Xin Zhang, Zhi-Bin Lin, et al.
Journal of Medicinal Chemistry|March 29, 2012
Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivoWei-Wei Li, Xiao-Yan Wang, Ren-Lin Zheng, et al.
Lancet (London, England)|July 24, 2020
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trialFeng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, et al.
Pageof 37